|
MRI Targeted Focal Laser Thermal Therapy of Biopsy Confirmed Prostate Cancer
The objective of this study is to establish the safety of MRI targeted laser thermal treatment for men with biopsy confirmed early stage low grade single sector prostate cancer. Participants will be asked to undergo MRI at 1 week, 3 months, and 6 months post surgery. As well a biopsy will be performed at the 6 the month mark. HRQOL Questionnaires will be collected at baseline, 1month, 3 month, and 6 month follow-up visits.
This study is suitable for men who have:
- Biopsy proven prostate cancer Gleason grade 6 or less
- No more than 40% of cores sampled positive
- Clinical stage T1c
- No prior prostate treatments (e.g. TURP, HIFU, Hormones)
- Subsequent MRI confirmation that tumor focus in same area as the biopsy
- PSA <10 ng/ml
For more information regarding this study contact:
Michael Nesbitt
(Clinical Research Coordinator)
telephone: 416-946-4501 ext. 6897
e-mail: michael.nesbitt@uhn.on.ca
|
For information on prostate cancer prevention trials being conducted at The Prostate Centre, click here.
|
